lorazepam has been researched along with Acute Kidney Injury in 8 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " He received a high-dose lorazepam infusion for alcohol withdrawal during hospitalization and developed severe hyperosmolality, high anion gap metabolic acidosis, and acute kidney injury on his eighth day of hospitalization." | 7.74 | Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam. ( Graeber, C; Sullivan, A; Yusufzai, I; Zar, T, 2007) |
| " Risk factors for the disease include older age, renal dysfunction, critical illness, and inappropriate dosing based upon renal function." | 5.56 | Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert. ( Allyn, R; Cunningham, JM; Sachs, KV, 2020) |
| " He received a high-dose lorazepam infusion for alcohol withdrawal during hospitalization and developed severe hyperosmolality, high anion gap metabolic acidosis, and acute kidney injury on his eighth day of hospitalization." | 3.74 | Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam. ( Graeber, C; Sullivan, A; Yusufzai, I; Zar, T, 2007) |
| " Risk factors for the disease include older age, renal dysfunction, critical illness, and inappropriate dosing based upon renal function." | 1.56 | Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert. ( Allyn, R; Cunningham, JM; Sachs, KV, 2020) |
| "While neuroleptic malignant syndrome (NMS) is typically characterised by delirium, motor rigidity, fever and dysautonomia, the syndrome is not pathognomonic, and NMS remains a diagnosis of exclusion." | 1.51 | Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach. ( Barahona-Corrêa, JB; Neves, A; Oliveira-Maia, AJ; Velosa, A, 2019) |
| " The acute kidney injury was treated by administration of intravenous fluid." | 1.48 | [A Lot of Hot Steam: the Cannabinoid Hyperemesis Syndrome]. ( Gericke, M; Hartmann, D, 2018) |
| "Twenty critically ill patients with acute renal failure on CVVH therapy were administered either lorazepam (n = 10) or midazolam (n = 10) by continuous infusion." | 1.33 | Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration. ( Danhof, M; de Jongh, J; Strack van Schijndel, RJ; Swart, EL; Thijs, LG; Zuideveld, KP, 2005) |
| " A full pharmacokinetic time profile of lithium was obtained." | 1.31 | Bayesian pharmacokinetics of lithium after an acute self-intoxication and subsequent haemodialysis: a case report. ( Beijnen, JH; Kerbusch, T; Mathôt, RA; Meesters, EW; Otten, HM; Schellens, JH; van Kan, HJ, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cunningham, JM | 1 |
| Sachs, KV | 1 |
| Allyn, R | 1 |
| Gericke, M | 1 |
| Hartmann, D | 1 |
| Velosa, A | 1 |
| Neves, A | 1 |
| Barahona-Corrêa, JB | 1 |
| Oliveira-Maia, AJ | 1 |
| Hayman, M | 1 |
| Seidl, EC | 1 |
| Ali, M | 1 |
| Malik, K | 1 |
| Swart, EL | 1 |
| de Jongh, J | 1 |
| Zuideveld, KP | 1 |
| Danhof, M | 1 |
| Thijs, LG | 1 |
| Strack van Schijndel, RJ | 1 |
| Zar, T | 1 |
| Yusufzai, I | 1 |
| Sullivan, A | 1 |
| Graeber, C | 1 |
| Parmar, MS | 1 |
| Kerbusch, T | 1 |
| Mathôt, RA | 1 |
| Otten, HM | 1 |
| Meesters, EW | 1 |
| van Kan, HJ | 1 |
| Schellens, JH | 1 |
| Beijnen, JH | 1 |
8 other studies available for lorazepam and Acute Kidney Injury
| Article | Year |
|---|---|
Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Anticonvulsants; Aphasia; Brain Diseases; Cefepime | 2020 |
[A Lot of Hot Steam: the Cannabinoid Hyperemesis Syndrome].
Topics: Abdominal Pain; Acute Kidney Injury; Adult; Combined Modality Therapy; Fluid Therapy; Humans; Loraze | 2018 |
Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach.
Topics: Acute Kidney Injury; Adult; Anticonvulsants; Antipsychotic Agents; Bromocriptine; Diagnosis, Differe | 2019 |
Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole.
Topics: Acute Kidney Injury; Cross Infection; Humans; Injections, Intravenous; Lorazepam; Male; Middle Aged; | 2003 |
Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
Topics: Acute Kidney Injury; Adult; Aged; Conscious Sedation; Drug Administration Schedule; Drug Evaluation; | 2005 |
Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam.
Topics: Acidosis; Acute Kidney Injury; Alcohol Withdrawal Delirium; Anti-Anxiety Agents; Drug Compounding; H | 2007 |
Re: Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam.
Topics: Acidosis; Acute Kidney Injury; Anti-Anxiety Agents; Drug Compounding; Humans; Lorazepam; Osmolar Con | 2007 |
Bayesian pharmacokinetics of lithium after an acute self-intoxication and subsequent haemodialysis: a case report.
Topics: Acute Disease; Acute Kidney Injury; Adult; Antimanic Agents; Antipsychotic Agents; Bayes Theorem; Bi | 2002 |